Weighted Average Number of Shares Outstanding, Basic of Renalytix plc from 30 Jun 2020 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Renalytix plc quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2020 to 30 Sep 2024.
  • Renalytix plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2024 was 105,697,401, a 12% increase year-over-year.
  • Renalytix plc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 108,179,366, a 32% increase from 2023.
  • Renalytix plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 82,210,050, a 13% increase from 2022.
  • Renalytix plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 72,861,448, a 1.9% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Renalytix plc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 105,697,401 +10,929,560 +12% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2024 2025 Q1
Q2 2024 108,179,366 +25,969,316 +32% 01 Apr 2024 30 Jun 2024 10-K 30 Sep 2024 2024 FY
Q1 2024 97,654,961 +12,094,178 +14% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 97,268,051 +22,376,207 +30% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 94,767,841 +19,963,129 +27% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024 2025 Q1
Q2 2023 82,210,050 +9,348,602 +13% 01 Apr 2023 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q1 2023 85,560,783 +13,263,474 +18% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q3
Q4 2022 74,891,844 +2,605,903 +3.6% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q2
Q3 2022 74,804,712 +2,573,909 +3.6% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q2 2022 72,861,448 01 Apr 2022 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q1 2022 72,297,309 +262,183 +0.36% 01 Jan 2022 31 Mar 2022 6-K 09 Jun 2023
Q4 2021 72,285,941 01 Oct 2021 31 Dec 2021 6-K 30 Mar 2023
Q3 2021 72,230,803 01 Jul 2021 30 Sep 2021 6-K 30 Nov 2022
Q1 2021 72,035,126 01 Jan 2021 31 Mar 2021 6-K 30 Jun 2022

Renalytix plc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 108,179,366 +25,969,316 +32% 01 Jul 2023 30 Jun 2024 10-K 30 Sep 2024 2024 FY
2023 82,210,050 +9,348,602 +13% 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024 2024 FY
2022 72,861,448 +1,376,514 +1.9% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023 2023 FY
2021 71,484,934 +12,405,412 +21% 01 Jul 2020 30 Jun 2021 20-F 31 Oct 2022 2022 FY
2020 59,079,522 01 Jul 2019 30 Jun 2020 20-F 31 Oct 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.